A First-in-Human Dose-Finding Phase I Study of Bone-targeted High Specific Activity Stannic-117m Pentatate (Sn-117m-DTPA) in Solid Tumors With Skeletal Metastases
NCT06982222 · NOT YET RECRUITING · Phase 1
ReadTheTrial indexes 7 studies for Anatomic Stage Iv Breast Cancer Ajcc V8. The most common development stage is N/A (3 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
7 clinical trials found for Anatomic Stage Iv Breast Cancer Ajcc V8.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 3 | 43% |
| Phase 2 | 2 | 29% |
| Phase 1 | 1 | 14% |
| Phase 3 | 1 | 14% |
There are 7 clinical trials listed for Anatomic Stage Iv Breast Cancer Ajcc V8. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Anatomic Stage Iv Breast Cancer Ajcc V8 trials are distributed across: N/A (3), Phase 2 (2), Phase 1 (1), Phase 3 (1).